Table 1 –
List of pathogenic mutations in BRCA1/2 or ATM observed in our cohort
ID | Gene | Mutation |
Platform used for detection | ||
---|---|---|---|---|---|
Origin | Name | Mechanism | |||
1 | BRCA2 | Somatic | p.N899I fs*5; p.K1691N fs*15 | Frameshift deletions | PGDx-Cancer Select |
2 | BRCA2 | Germline | p.Y2215S fs*13 | Frameshift deletion | Color Genomics |
3 | ATM | Germline | p.S1905I fs*25 | Frameshift insertion | Color Genomics |
4 | BRCA2 | Germline | p.N319K fs*8 | Frameshift insertion | Color Genomics |
5 | BRCA2 | Germline | p.D3095E | Missense | Color Genomics |
6 | ATM | Somatic | p.Q284X* | Nonsense | PGDx-Plasma Select |
7 | BRCA2 | Germline | p.D156X* | Nonsense | Color Genomics |
8 | BRCA2 | Germline | p.W1692M fs*3 | Frameshift insertion | Color Genomics |
9 | BRCA2 | Somatic | p.S1982R fs*22 | Frameshift deletion | Foundation One |
10 | BRCA1 | Germline | p.Y1463X* | Nonsense | Color Genomics |
11 | BRCA1 | Germline | c.4357+1G>A | Splicing | Color Genomics |
12 | ATM | Somatic | Loss of exons 30–34 | Rearrangement | Foundation One |
13 | BRCA2 | Germline | p.S3147C fs*2 | Frameshift deletion | Myriad genetics |
14 | BRCA2 | Germline | p.Q2858A fs*5 | Frameshift insertion | Caris Genetics |
15 | BRCA2 | Somatic | p.F1546L fs*22 | Frameshift deletion | Foundation One |
16 | ATM | Somatic | p.M1V | Missense | Foundation One |
17 | ATM | Somatic | p.N405K fs*15 | Frameshift deletion | Foundation One |
18 | ATM | Somatic | 1.7 kbp deletion | Rearrangement | UW-Oncoplex |
19 | BRCA2 | Germline | p.L1908R fs*2 | Frameshift deletion | Myriad genetics |
20 | BRCA2 | Germline | p.T2125P fs*12 | Frameshift deletion | Color Genomics |
21 | BRCA2 | Germline | Exon loss, with hemizygous deletion of somatic allele | Rearrangement | Stand Up 2 Cancer (Ml-OncoSeq) |
22 | BRCA2 | Somatic | Homozygous deletion | Rearrangement | Stand Up 2 Cancer (MI-OncoSeq) |
23 | BRCA2 | Somatic | Homozygous deletion | Rearrangement | UW-Oncoplex |